Ypsomed Holding AG

Ypsomed Holding AG is a leading Swiss medical technology company specializing in the development and manufacturing of injection and infusion systems for self-medication. Renowned as a diabetes specialist, the company plays a significant role in facilitating the treatment of chronic conditions such as diabetes, infertility, and growth disorders through innovative devices like autoinjectors, insulin pumps, and pen injectors. Ypsomed serves both consumers and business clients by delivering its product portfolio directly to patients, pharmacies, and hospitals under the mylife Diabetescare brand and collaborating with pharmaceutical and biotechnology companies through Ypsomed Delivery Systems. With a global network of production facilities and distribution partners, the company maintains a strong presence in Switzerland, Europe, and North America. As a pioneer in user-friendly medical devices, Ypsomed supports advancements in patient self-care and contributes to the broader healthcare ecosystem through technology, services, and strategic partnerships.